Banco Bilbao Vizcaya Argentaria S.A. Has $27.36 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 26.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 53,832 shares of the healthcare conglomerate’s stock after selling 19,795 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in UnitedHealth Group were worth $27,361,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Sugarloaf Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Signal Advisors Wealth LLC increased its position in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the period. Waycross Partners LLC lifted its holdings in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares during the period. Czech National Bank increased its holdings in UnitedHealth Group by 6.1% in the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after purchasing an additional 11,426 shares during the period. Finally, Lmcg Investments LLC lifted its holdings in UnitedHealth Group by 11.8% during the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock worth $19,210,000 after buying an additional 4,022 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $428.25 on Thursday. The firm has a market capitalization of $391.73 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $417.12 and a 52 week high of $630.73. The stock has a 50 day moving average price of $506.92 and a two-hundred day moving average price of $537.23.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on UNH shares. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. KeyCorp dropped their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating on the stock in a report on Monday. Oppenheimer lowered their price objective on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating for the company in a research report on Monday. Finally, Barclays decreased their target price on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research note on Monday. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $604.67.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.